What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Wed, Jan. 6, 12:45 PM
Nov. 17, 2015, 12:47 PM
Nov. 16, 2015, 4:04 PM
- Marathon Patent (NASDAQ:MARA): Q3 EPS of -$0.26 beats by $0.02.
- Revenue of $6.4M (-52.4% Y/Y) beats by $1.6M.
Oct. 2, 2015, 9:54 AM
- An Eastern Michigan federal court has denied a joint motion by Ford and Fiat Chrysler to stay all proceedings for Marathon Patent's (NASDAQ:MARA) infringement suits against the companies pending patent reexamination and inter partes reviews.
- The cases were moved to Michigan from California's Central District (CDCA) in May. Trials for 8 cases still in CDCA are expected to commence on March 15, 2016.
- Two months ago: Marathon merging with Luxembourg's Uniloc
Aug. 14, 2015, 5:49 PM
- Along with its Q2 results, Marathon Patent Group (NASDAQ:MARA) announces it's merging with Uniloc, an owner of security tech patents, in an all-stock deal.
- Marathon investors will own 45% of the post-merger company, and Uniloc investors 55%. The new company will be known as Marathon Group, and be domiciled in low-tax Luxembourg. Current Marathon chairman/CEO Doug Croxall will retain his position; Uniloc CEO Craig Etchegoyen will be chief IP officer. Unlioc CFO Drake Turner will be Marathon Group's CFO, and current Marathon CFO Francis Knuettel its COO.
- Marathon/Uniloc have $37.5M in combined licensing revenue over the last 12 months, and expect to have active litigation against 119 alleged infringers through 2017. The companies have a combined portfolio of 662 patents.
- Update (6:14PM ET): Marathon is up 11.3% in AH trading following the news.
Aug. 14, 2015, 5:10 PM
- Marathon Patent (NASDAQ:MARA): Q2 EPS of -$0.32 in-line.
- Revenue of $1.37M (-64.1% Y/Y) misses by $2.9M.
Jul. 2, 2015, 12:04 PM
- In a preliminary opinion, a Munich court has ruled Joline GmbH, Signus Medizintechnik GmbH and PanMedical infringe Marathon's (MARA +2.8%) '260 European patent.
- The decision follows a June 19 ruling upholding the validity of the patent's claims, following a challenge by Stryker. Marathon says it's seeking "an equitable licensing agreement, much like the one just executed with Maxxspine Limited, which involves a lump sum royalty payment for products already sold, as well as a running royalty rate for future sales."
- Shares are up moderately. They tumbled last month after a Delaware jury ruled against Marathon partner Bridgestone in an infringement suit.
Jun. 12, 2015, 12:45 PM
Jun. 11, 2015, 12:29 PM
- A Delaware jury has ruled against tire maker Bridgestone in its infringement suit against Schrader-Bridgeport International. Marathon (NASDAQ:MARA) had "advised [Bridgestone] and provided substantially all of the financing of this litigation," and owns "contract rights to the revenue associated with the outcome of this case."
- Marathon CEO Doug Croxall: "We are clearly disappointed by the jury's ruling. It is a decision Bridgestone will promptly appeal as we believe the jury erred in their verdict. This outcome has no bearing on our German case and we remain confident in the validity and infringement of our European patent ... Marathon has invested in a diversified portfolio consisting of 413 patents across 19 different subsidiaries, 12 of which are in active litigation with approximately 50 defendants."
- Shares had plunged on the verdict before Marathon put out a PR. They remain at their lowest levels since 2013.
Jun. 11, 2015, 11:06 AM
- Marathon Patent (NASDAQ:MARA) has cratered on volume of 1.54M shares, far above a 3-month daily average of 105K.
- No news has hit the wires yet, but drops of this magnitude for IP licensing firms are typically due to legal setbacks ... of which there have been many for the group over the last year.
- Update: A jury ruling in an infringement suit by Marathon partner Bridgestone was the culprit.
Jun. 9, 2015, 4:04 PM
- Marathon Patent's (NASDAQ:MARA) MedTech Development and Orthophoenix subsidiaries have entered into a license agreement. The licensee's name is undisclosed due to a confidentiality agreement.
- The deal is said to cover "the German parts of European patent EP 1 938 765 B1 and EP 1 104 260 B2, both of which have been asserted in Germany and relate to medical devices involved in kyphoplasty surgery." Marathon adds Orthophoenix's patent portfolio covers IP related to bone-treatment techniques.
- Marathon rallied today on volume of 520K shares; the 3-month daily average is 95K. Licensing deals with Thomson Reuters and Nordstrom were announced last week.
May 14, 2015, 4:02 PM
- Marathon Patent (NASDAQ:MARA): Q1 EPS of -$0.19 misses by $0.09.
- Revenue of $4.09M (+47.1% Y/Y) misses by $1.44M.
Apr. 10, 2015, 2:10 PM
- Under pressure for much of 2015, Marathon Patent Group (NASDAQ:MARA) has jumped higher today on volume of 169K shares (above a 3-month daily average of 102K). Shares remain down 31% YTD.
- Yesterday, Marathon announced it's suing Yahoo in Germany for allegedly infringing the German part of a European patent via Flickr. On Tuesday, the company announced a settlement/licensing deal with medical device maker Varian Medical.
Mar. 30, 2015, 3:13 PM
- Today's notable tech gainers include industrial laser maker IPG Photonics (IPGP +4.3%), cloud classroom software provider 2U (TWOU +5.8%), California solar installer Solar3D (SLTD +10.3%), Korean analog/mixed-signal chipmaker MagnaChip (MX +6.8%), privileged account security software vendor CyberArk (CYBR +5.3%), haptic tech provider Immersion (IMMR +4.6%), and solar power optimizer maker/recent IPO SolarEdge (SEDG +4.8%). The Nasdaq is up 1.1%.
- There are relatively few major decliners. The group includes Chinese online video platform Youku (YOKU -4.5%), Chinese solar cell/module maker Yingli (YGE -5.6%), authentication hardware/software provider Vasco (VDSI -3%), and IP licensing firm Marathon Patent Group (MARA -8.8%).
- Solar3D is now up 97% from a March 18 close of $2.57. SolarEdge is up 23% from last week's $18 IPO price. Immersion might be getting a lift from a Barclays report stating Analog Devices will be supplying converter ICs to help enable haptics support on future iPhones/iPads.
- Youku has fallen to fresh 52-week lows, and is now down 18% since posting Q4 results and disclosing an SEC inquiry on March 19. Marathon is down 11% since reporting last Thursday.
- Previously covered: BlackBerry, Altera, Ambarella, OTI, Angie's List, You On Demand, 500.com, Chinese online real estate
Mar. 26, 2015, 4:10 PM
- Marathon Patent (NASDAQ:MARA): FY'14 EPS of $0.36 vs. -$0.03 in FY'13
- Revenue of $21.4M (+526% Y/Y)
- Shares +4.5%.
Feb. 8, 2015, 3:32 PM
- Rep. Bob Goodlatte (R-VA) has introduced a new version of the Innovation Act, a bill aiming to make it tougher for IP licensing firms (often referred to by critics as patent trolls) to pursue infringement suits. The original Innovation Act was shelved 9 months ago by Sen. Pat Leahy (D-VT), reportedly at the behest of then-Senate Majority Leader Harry Reid (D-NV). With the Republicans now controlling the Senate, the new version might have better odds.
- Among other things, the bill: 1) Requires plaintiffs to disclose a patent's owner prior to litigation, and explain why they're suing a company in proceedings. 2) Requires courts to make a decision on a patent's validity early in the litigation process. 3) Requires judges to award attorney's fees to defendants for frivolous claims. 4) Requires the Judicial Conference to create rules lowering the costs of the discovery process during litigation, so that "patent trolls cannot use the high costs of discovery to extort money." 5) Creates "a voluntary process for small businesses to postpone expensive patent lawsuits."
- Not surprisingly, Goodlatte's bill has been praised by an IT/telecom trade group - "We finally have a bill that would create a bit of gridlock for patent trolls’ extortion schemes." And it has been harshly criticized by a trade group representing IP licensors. "[T]he bill being introduced is over broad and does not take into account the many developments that have taken place over the past year in the patent landscape..."
- As it is, the last two years have seen the White House issue executive actions and legislative proposals aimed at curtailing patent law abuses, the Supreme Court set limits on software patents (while upholding software's patentability), and lower federal courts issue a string of adverse rulings against various firms pursuing infringement claims.
- IP licensing firms: ACTG, VRNG, VHC, SPEX, WILN, MARA, FNJN, OTCQB:WDDD, PRKR, DSS
Marathon Patent Group Inc is a patent and patent rights acquisition and licensing company. The Company acquires patents and patent rights from their owners, who range from individual inventors to Fortune 500 companies.
Other News & PR